Nicotinamide adenosine dinucleotide (NAD) and its phosphorylated form (NADP) are 15 essential metabolites that are key cofactors for many redox enzymes and co-substrates 16 for several protein modification enzymes. It is difficult to study and manipulate the 17 functions of NAD(P), because these cofactors participate in complex metabolic 18 network. NAD analogs can reduce the complexity by bioorthogonalization of 19 metabolic modules and enhance our ability to understand and regulate the 20 bioenergetic and signaling pathways mediated by NAD. But the design and 21 application of NAD analogs is limited because these compounds cannot be easily 22 delivered into cells. Here we explored the strategy to import those adenine-replaced 23 NAD analogs (NXDs) into Escherichia coli cells. We showed that the transporter 24 NTT4 derived from Protochlamydia amoebophila was efficient for NXDs import. By 25 constructing an ushA-deletion mutant, we improved extracellular stability of NXDs 26 significantly and realized continuous import upon concurrent expression of NTT4.
INTRODUCTION
improve cofactor stability. 116 Here we optimize the importing efficiency of pyridine nucleotide cofactors in E. 117 coli by choosing an efficient transporter and deleting ushA gene encoding the main 118 pyrophosphatase for the decomposition of exogenous cofactors. Then pyridine 119 nucleotide cofactors can be directly introduced in a continuous and efficient way. We 120 import NAD analogs with the adenine replaced by other bases (NXDs, Fig. 1A ) via 121 the strategy, and then characterize biological functions of NXDs.
122

RESULTS
123
Identification of efficient NAD analog transporter 124 Among the well characterized NAD transporters, AtNDT2 derived from A. 125 thaliana mitochondria shows the widest substrate spectrum and the highest activity 126 (12, 15). AtNDT2 has been applied to importing NCD for construction of in vivo 127 metabolic circuits, but the importing efficiency is insufficient for further study and 128 application (5).To date, P. amoebophila UWE25 derived NTT4 has been proved an 129 excellent NAD transporter by heterologous expression in E. coli, but its substrate 130 spectrum has not been well studied (14, 22) . 131 To evaluat the importing efficiency of NAD analogs by AtNDT2 and NTT4, four 132 NXDs was designed by substituting the adenine group of NAD with natural bases 133 (Fig. 1A) . The NXD with natural base might have excellent biocompatibility and can 134 be synthesized via modified endogenetic NAD salvage pathways (13), which will 135 facilitate in vivo applications of characterized NXDs. Based on the structure similarity, 136 NAD and NGD with purine group might have similar character, and possess different 137 properties toward NCD, NTD and NUD with pyrimidine group. NAD and NCD were 138 chosen for preliminary design and characterization of efficient NXD import strategy. 139 The cofactor transporting efficiency of NTT4 and AtNDT2 was compared by 140 expressing the transporters with constitutive promoter gntT105P of the plasmid 141 pBCTD in the strains WL023 and WL024, respectively. To correct for endogenetic 142 synthesis of NAD, we subtracted the background NAD concentration from the control 143 strain incubated without exogenous cofactors. Compared with AtNDT2, NTT4 was a 144 more efficient transporter for both NAD and NCD ( Fig. 1B) . With 0.1 mM 145 exogenously added cofactors, NTT4 increased the cellular NAD and NCD level by 146 7 1.8 mM and 1.2 mM, respectively, while AtNDT2 only increased the cellular NAD 147 and NCD level by 0.5 mM and 0.1 mM, respectively. Both NTT4 and AtNDT2 148 preferred NAD to NCD. NTT4 could concentrate exogenous cofactor into cells via 149 counter exchange with ADP, and made an 12 fold higher intracellular NCD 150 concentration than the exogenously added 0.1 mM NCD.
151
NCD is primarily designed for pathway specific energy transformation in cellular 152 environment, and its influence on cell growth will affect the in vivo application. NCD 153 had no detectable influence on cell growth of WL023 when exogenously added at 0.1 154 mM, which indicated that NCD has an excellent biocompatibility. Reducing extracellular cofactor degradation 164 Because NAD analogs are added extracellularly for further in vivo utilization, 165 their stability in the environment has to be evaluated. As UshA is a major periplasmic 166 enzyme for NAD degradation in E. coli, it is expected that cofactor degradation 167 should be significantly reduced of the ushA deletion mutant ( Fig. 2A ). As storage at 168 −80 °C had little influence on intracellular cofactor and cofactor uptake ( Fig. 2B ), the 169 frozen cells were used for investigating cofactor uptake.
170
Extracellular NAD and NCD stability in the presence of wild type strain cells Characterizing NTT4 binding of NXD 228 The efficient cofactor importing strain WL023 may be also applicable to import 229 of other NXDs with purine group or pyrimidine group. The binding of NXDs to 230 NTT4 was characterized by inhibition of the uptake of NAD ( Fig. 3A) (14, 25).
231
WL023 cells were incubated with 50 μM of NAD and a 10 fold excess of the NXD.
232
NGD potently inhibited NAD uptake (89.9% inhibition), while NCD, NTD and NUD 233 inhibited uptake much less efficiently (37.0%, 43.6% and 52.8% inhibition, (Fig. 3C) , which suggested the nucleotide precursors had little impact on NAD 252 metabolism.
253
When supplemented WL023 cells with 0.5 mM of NGD, the intracellular NAD 254 concentration was lower than the sample without NGD (Fig. 3D, p-value=0 .002). This 255 suggested NGD potently inhibited intracellular NAD synthesis. Intact NGD was 256 necessary for the inhibition of NAD synthesis, and its degradation products 257 (guanosine and NR) did not impress NAD synthesis (Fig. 3D ). carried out at an initial OD 600 of 1 in MOPS medium, and incubated with agitation at 30 °C for 8 h. 267
The data represent the average standard deviations of three independent experiments. 268 269 Besides NAD and NADP, in vivo NCD and NGD have also been reported The YJE003 cells were cultivated with 50 μM of exogenous NXD at an initial 281 OD 600 of 0.3 (Fig. 4A) . The cell density of YJE003 increased to 2.5 fold in LB 282 medium without cofactor supplementation, and grew to an OD 600 of 1.5 with NAD. Efficient import of pyridine nucleotide cofactor analogs will enhance our ability 320 to control in vivo modified pyridine nucleotide cofactor concentrations. To expand the 321 strategy to other organisms, the optimal transporter may be varying, but NTT4 may be 322 practical for most bacteria. Single deletion of ushA in E. coli greatly increased 323 15 stability of exogenous NXDs, and such strategy may also be practical for other 324 organisms, for example deletion of CD37 in human cells may decrease the 325 degradation of extracellular NAD analogs (20). Cofactor decomposition prefers 326 cofactors with bigger group at nucleotide side (19). So NAD was more stable than 327 NCD and excess amount of NCD could improve stability of exogenous added NAD.
Utilization of NXD by E. coli
328
Meanwhile NGD with bigger nucleotide group has little improvement on NAD 329 stability. That is, we have to design cofactor analogs with bigger group at nucleotide 330 side for higher stability or design analogs with smaller group as protectors of target 331 cofactor. According to in vivo NCD degradation, there is little pyrophosphatase 332 activity inside cell, so efficient import of NXDs is an alternative strategy for 333 improving NXD stability.
334
The NAD auxotrophic mutant YJE003 can be employed to screening different 
359
Bacterial strains and plasmids 360 The strains and plasmids used are listed in Table 2 . Deletion of ushA was 361 performed originally from the strain JW0469 with ushA::kan mutant as described 50 °C for 10 min, then the mixtures were neutralized by 0.1 volume of 1 M NaOH.
378
All the samples were stored at -80 °C before NAD or NCD concentration analysis.
379
The cell density was correlated to the intracellular volume with 0.63 mL/L equivalent 380 to an OD 600 of 1 (31).
381
Analytic methods
382
NAD and NCD were assayed by enzymatic cycling assays. NAD concentration 383 was assayed by ADH as described previously 31 . NCD was assayed by Mae*, and the 
